MELACINE DIN 02241211
Health Canada record
| Active ingredient(s) | MELANOMA LYSATE 20000000 CELLS; MONOPHOSPHORYL LIPID A 50 MCG; CELL WALL SKELETON 500 MCG |
|---|---|
| Dosage form | Powder; Kit |
| Route | Intramuscular |
| Schedule | SCHEDULE D; PRESCRIPTION |
| Class | Human |
| ATC | L03AX12 MELANOMA VACCINE |
| Original market date | 25-Jan-2001 |
| Current status date | 30-Jul-2005 |
| Source | Health Canada DPD |
Establishment licence of the holder
Corixa Corporation dba GlaxoSmithKline Vaccines — licence , not currently licensed, last inspection rating C (2025-06-09).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 1908 | 1999-11-04 | New Drug Submission (NDS) |